A Study of BGB-11417 in Participants With Myeloid Malignancies

Clinical trial NCT04771130 · RECRUITING

Trial details

NCT number: NCT04771130
Sponsor: BeOne Medicines
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm

Start date: 2021-05-24
Primary completion: 2028-02-08
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.